Prenatal exposure to TAK242 affects the childhood autism in offspring in animal models of autism spectrum disorder

Document Type: Original Article

Authors

1 The Children’s Neurorehabilitation Center, the First Affiliated Hospital, Anhui Medical University, Hefei 230022, Anhui, China

2 Department of Pediatrics, the First Affiliated Hospital, Anhui Medical University, Hefei 230022, Anhui, China

Abstract

Objective(s): To evaluate whether prenatal exposure to TAK242 affects childhood autism in the offspring in animal models of autism spectrum disorder (ASD).
Materials and Methods:The pregnant rats were pseudo-randomly divided into three groups, the ASD model group, the TAK242 treatment group, and the control group. The ASD model was constructed by injecting IP with LPS. The blood samples from 1-month-old offspring were collected for cytokine evaluation and the social interaction test was used in the offspring of ASD rats. Rats were killed and the hippocampus, cerebral cortex, and cerebellum were used for the immunohistochemical study.
Results: As compared to the control, the levels of IFN-γ, IL-1β, IL-2, and IL-6 were significantly increased (P<0.05), and the levels of IL-4, IL-10, and TGF-β were significantly decreased (P <0.05) in the offspring of ASD rats; whereas those cytokines were significantly reversed after prenatal exposure to TAK242 (P<0.05). The hesitation time and none-social interaction time were significantly increased as compared to the control (P<0.05); whereas they were both decreased after prenatal exposure to TAK242 (P<0.05). This was contrary to the social interaction time (P<0.05). The expression of GFAP and IBA1 in the cortex, hippocampus, and cerebellum were stronger in the LPS group as compared to control group, and this effect was reversed after prenatal exposure to TAK242.
Conclusion: Prenatal exposure to TAK242 affects serum cytokines levels and the social interaction time in rat offspring in animal models of ASD.

Keywords


1. Moy SS, Nadler JJ, Magnuson TR, Crawley JN. Mouse models of autism spectrum disorders: the challenge for behavioral genetics. Am J Med Genet C Semin Med Genet 2006; 142c:40-51.

2. Malkova NV, Yu CZ, Hsiao EY, Moore MJ, Patterson PH. Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism. Brain Behav Immun 2012; 26:607-616.

3. Wink LK, Plawecki MH, Erickson CA, Stigler KA, Mcdougle CJ. Emerging drugs for the treatment of symptoms associated with autism spectrum disorders. Exp Opin Emerg Drugs 2010; 15:481-494.

4. Pardo CA, Vargas DL, Zimmerman AW. Immunity, neuroglia and neuroinflammation in autism. Int Rev Psychiatry 2006; 17:485-495.

5. Li X, Chauhn AA, Shiekh AAM, Patil AS, Chauhn BV, Li XM, et al. Elevated immune response in the brain of autistic patients. J Neuroimmunol 2009; 207:111-116.

6. Medzhitov R. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol Nat Rev Immunol 2001; 1:135-145.

7. Lucas K, Maes M. Role of the toll like Receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway. Mol Neurobiol 2013; 48:190-204.

8. Rice TW, Wheeler AP, Bernard GR, Vincent JL, Angus DC, Aikawa N, et al. A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis. Crit Care Med 2010; 38:1685-1694.

9. Kawamoto T, Ii M, Kitazaki T, Iizawa Y, Kimura H. TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain. Eur J Pharmacol 2008; 584:40-48.

10. Xuan ICY. The maternal immune activation mouse model of autism spectrum disorders. Master 2013; 4:e400.

11. Goines PE, Croen LA, Braunschweig D, Yoshida CK, Grether J, Hansen R, et al. Increased midgestational IFN-γ, IL-4 and IL-5 in women bearing a child with autism: A case-control study. Mol Autism 2011; 2:13.

12. Brodkin ES, Hagemann A, Nemetski SM, Silver LM. Social approach-avoidance behavior of inbred mouse strains towards DBA/2 mice. Brain Res 2004; 1002:151–157.

13. Ferretti CJ, Hollander E. The role of inflammation in Autism Spectrum Disorder. Immunol Psychiatry 2015; 275-312.

14. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 2000; 406:782-787.

15. Sato A, Mizuguchi M, Ikeda K. Social interaction test: a sensitive method for examining autism-related behavioral  deficits. Protocol Exchange 2013.

16. de Oliveira WH, Ak DSN, de França ME, Dos Santos LA, Lós DB, Santos Rocha SW, et al. Effects of metformin on inflammation and short-term memory in streptozotocin-induced diabetic mice. Brain Res 2016; 1644:149-160.

17. Park T, Chen H, Kevala K, Lee JW, Kim HY. N-Docosahexaenoylethanolamine ameliorates LPS-induced neuroinflammation via cAMP/PKA-dependent signaling. J Neuroinflammation 2016; 13:284.

18. Norden DM, Trojanowski PJ, Villanueva E, Navarro E, Godbout JP. Sequential activation of microglia and astrocyte cytokine expression precedes increased iba-1 or GFAP immunoreactivity following systemic immune challenge. Glia 2015; 64:300-316.